Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Pasupuleti, Mukesh ^a   Davoudi, Mina ^a   Malmsten, Martin ^b   Schmidtchen, Artur ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 77049089782     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-136     Document Type: Article

References (30)

1. Advances in antimicrobial peptide immunobiology. NY Yount AS Bayer YQ Xiong MR Yeaman, Biopolymers 2006 84 435 458 10.1002/bip.20543 16736494
2. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? KA Brogden, Nat Rev Microbiol 2005 3 238 250 10.1038/nrmicro1098 15703760
3. Antimicrobial peptides: A natural alternative to chemical antibiotics and a potential for applied biotechnology. SH Marshall, Electronic Journal of Biotechnology 2003 6 3 http://www.ejbiotechnology.info/content/vol6/issue3/full/ 1/BIP/index.html
4. Expression of extracellular superoxide dismutase by human cell lines. SL Marklund, Biochem J 1990 266 213 219 2106874
5. Extracellular superoxide dismutase in human tissues and human cell lines. SL Marklund, J Clin Invest 1984 74 1398 1403 6541229 10.1172/JCI111550
6. Characterization of the heparin-binding domain of human extracellular superoxide dismutase. LA Tibell I Sethson AV Buevich, Biochim Biophys Acta 1997 1340 21 32 9217011
7. Inhibition of oxygen toxicity by targeting superoxide dismutase to endothelial cell surface. M Inoue N Watanabe Y Morino Y Tanaka T Amachi J Sasaki, FEBS Lett 1990 269 89 92 10.1016/0014-5793(90)81126-9 2387419
8. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Sandstrom L Carlsson SL Marklund T Edlund, J Biol Chem 1992 267 18205 18209 1517248
9. Characterization of heparin binding of human extracellular superoxide dismutase. A Lookene P Stenlund LA Tibell, Biochemistry 2000 39 230 236 10.1021/bi991512x 10625498
10. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. A Schmidtchen IM Frick L Björck, Mol Microbiol 2001 39 708 713 10.1046/j.1365-2958.2001.02251.x 11169110
11. Antimicrobial activities of heparin-binding peptides. E Andersson V Rydengård A Sonesson M Mörgelin L Björck A Schmidtchen, Eur J Biochem 2004 271 1219 1226 10.1111/j.1432-1033.2004.04035.x 15009200
12. Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. L Kacprzyk V Rydengard M Morgelin M Davoudi M Pasupuleti M Malmsten A Schmidtchen, Biochim Biophys Acta 2007 1768 2667 2680 10.1016/j.bbamem.2007. 06.020 17655823
13. Activation of the complement system generates antibacterial peptides. EA Nordahl V Rydengård P Nyberg DP Nitsche M Mörgelin M Malmsten L Björck A Schmidtchen, Proc Natl Acad Sci USA 2004 101 16879 16884 15550543 10.1073/pnas.0406678101 (Pubitemid 39601332)
14. Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. M Pasupuleti B Walse EA Nordahl M Morgelin M Malmsten A Schmidtchen, J Biol Chem 2007 282 2520 2528 10.1074/jbc.M607848200 17132627
15. Domain 5 of high molecular weight kininogen is antibacterial. EA Nordahl V Rydengård M Mörgelin A Schmidtchen, J Biol Chem 2005 280 34832 34839 10.1074/jbc.M507249200 16091369
16. Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. M Malmsten M Davoudi A Schmidtchen, Matrix Biol 2006 25 294 300 10.1016/j.matbio.2006.04.003 16730966
17. Antimicrobial peptides derived from growth factors. M Malmsten M Davoudi B Walse V Rydengard M Pasupuleti M Morgelin A Schmidtchen, Growth Factors 2007 25 60 70 10.1080/08977190701344120 17454151
18. Histidine-rich glycoprotein exerts antibacterial activity. V Rydengard AK Olsson M Morgelin A Schmidtchen, Febs J 2007 274 377 389 10.1111/j.1742-4658. 2006.05586.x 17229145
19. Histidine-rich glycoprotein protects from systemic Candida infection. V Rydengard O Shannon K Lundqvist L Kacprzyk A Chalupka AK Olsson M Morgelin W Jahnen-Dechent M Malmsten A Schmidtchen, PLoS Pathog 2008 4 1000116 18797515 10.1371/journal.ppat.1000116
20. Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. M Pasupuleti B Walse B Svensson M Malmsten A Schmidtchen, Biochemistry 2008 47 9057 9070 10.1021/bi800991e 18690701
21. Antimicrobial proteins and peptides in host defense. T Ganz, Semin Respir Infect 2001 16 4 10 10.1053/srin.2001.22723 11309707
22. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. Y Wang B Agerberth A Lothgren A Almstedt J Johansson, J Biol Chem 1998 273 33115 33118 10.1074/jbc.273.50.33115 9837875
23. Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. L Ringstad L Kacprzyk A Schmidtchen M Malmsten, Biochim Biophys Acta 2007 1768 715 727 10.1016/j.bbamem.2006.11.016 17207456
24. Impact of LL-37 on anti-infective immunity. DM Bowdish DJ Davidson YE Lau K Lee MG Scott RE Hancock, J Leukoc Biol 2005 77 451 459 10.1189/jlb.0704380 15569695
25. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. UH Durr US Sudheendra A Ramamoorthy, Biochim Biophys Acta 2006 1758 1408 1425 10.1016/j.bbamem.2006.03.030 16716248
26. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. KA Henzler-Wildman GV Martinez MF Brown A Ramamoorthy, Biochemistry 2004 43 8459 8469 10.1021/bi036284s 15222757
27. Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells. N Sal-Man Z Oren Y Shai, Biochemistry 2002 41 11921 11930 10.1021/bi0260482 12269837
28. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. V Nizet, Curr Issues Mol Biol 2006 8 11 26 16450883
29. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Y Li TT Huang EJ Carlson S Melov PC Ursell JL Olson LJ Noble MP Yoshimura C Berger PH Chan DC Wallace CJ Epstein, Nat Genet 1995 11 376 381 10.1038/ng1295-376 7493016
30. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. S Elchuri TD Oberley W Qi RS Eisenstein L Jackson Roberts H Van Remmen CJ Epstein TT Huang, Oncogene 2005 24 367 380 10.1038/sj.onc.1208207 15531919